nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—Levothyroxine—hypothyroidism	0.244	0.266	CbGbCtD
Tolbutamide—SLCO1A2—Liothyronine—hypothyroidism	0.244	0.266	CbGbCtD
Tolbutamide—SLCO1A2—Liotrix—hypothyroidism	0.238	0.259	CbGbCtD
Tolbutamide—CYP2C8—Levothyroxine—hypothyroidism	0.0975	0.106	CbGbCtD
Tolbutamide—CYP2C8—Liotrix—hypothyroidism	0.0952	0.104	CbGbCtD
Tolbutamide—CYP2C19—urine—hypothyroidism	0.00478	0.0799	CbGeAlD
Tolbutamide—CYP2C9—urine—hypothyroidism	0.00371	0.0619	CbGeAlD
Tolbutamide—KCNJ11—heart—hypothyroidism	0.00231	0.0385	CbGeAlD
Tolbutamide—KCNJ11—cardiovascular system—hypothyroidism	0.00218	0.0364	CbGeAlD
Tolbutamide—ABCC8—heart—hypothyroidism	0.00213	0.0355	CbGeAlD
Tolbutamide—ABCC8—cardiovascular system—hypothyroidism	0.00201	0.0335	CbGeAlD
Tolbutamide—ABCC8—pituitary gland—hypothyroidism	0.00178	0.0297	CbGeAlD
Tolbutamide—KCNJ11—adrenal gland—hypothyroidism	0.00172	0.0288	CbGeAlD
Tolbutamide—CYP2C18—liver—hypothyroidism	0.00168	0.0281	CbGeAlD
Tolbutamide—SLCO2B1—heart—hypothyroidism	0.00166	0.0278	CbGeAlD
Tolbutamide—KCNJ11—thyroid gland—hypothyroidism	0.00166	0.0278	CbGeAlD
Tolbutamide—KCNJ11—female gonad—hypothyroidism	0.00161	0.0268	CbGeAlD
Tolbutamide—ABCC8—adrenal gland—hypothyroidism	0.00159	0.0265	CbGeAlD
Tolbutamide—SLCO2B1—Transport of organic anions—AVP—hypothyroidism	0.00155	0.075	CbGpPWpGaD
Tolbutamide—ABCC8—thyroid gland—hypothyroidism	0.00153	0.0256	CbGeAlD
Tolbutamide—KCNJ11—cerebellum—hypothyroidism	0.00132	0.022	CbGeAlD
Tolbutamide—ABCC8—testis—hypothyroidism	0.00131	0.0219	CbGeAlD
Tolbutamide—SLC15A2—heart—hypothyroidism	0.00127	0.0212	CbGeAlD
Tolbutamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00125	0.0606	CbGpPWpGaD
Tolbutamide—SLCO2B1—adrenal gland—hypothyroidism	0.00124	0.0207	CbGeAlD
Tolbutamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00121	0.0588	CbGpPWpGaD
Tolbutamide—ABCC8—cerebellum—hypothyroidism	0.00121	0.0202	CbGeAlD
Tolbutamide—SLCO2B1—thyroid gland—hypothyroidism	0.0012	0.02	CbGeAlD
Tolbutamide—SLC15A1—liver—hypothyroidism	0.00119	0.0198	CbGeAlD
Tolbutamide—SLCO2B1—female gonad—hypothyroidism	0.00116	0.0193	CbGeAlD
Tolbutamide—SLC15A2—pituitary gland—hypothyroidism	0.00106	0.0177	CbGeAlD
Tolbutamide—SLCO2B1—testis—hypothyroidism	0.00103	0.0172	CbGeAlD
Tolbutamide—SLCO2B1—liver—hypothyroidism	0.000971	0.0162	CbGeAlD
Tolbutamide—SLCO1A2—Transport of organic anions—AVP—hypothyroidism	0.000951	0.046	CbGpPWpGaD
Tolbutamide—CYP2C9—heart—hypothyroidism	0.00095	0.0159	CbGeAlD
Tolbutamide—SLCO2B1—cerebellum—hypothyroidism	0.000948	0.0158	CbGeAlD
Tolbutamide—SLC15A2—adrenal gland—hypothyroidism	0.000948	0.0158	CbGeAlD
Tolbutamide—SLC15A2—blood—hypothyroidism	0.000948	0.0158	CbGeAlD
Tolbutamide—SLCO1A2—testis—hypothyroidism	0.000945	0.0158	CbGeAlD
Tolbutamide—SLC15A2—thyroid gland—hypothyroidism	0.000915	0.0153	CbGeAlD
Tolbutamide—CYP2C19—blood—hypothyroidism	0.000915	0.0153	CbGeAlD
Tolbutamide—CYP2C9—cardiovascular system—hypothyroidism	0.000897	0.015	CbGeAlD
Tolbutamide—CYP2C8—pituitary gland—hypothyroidism	0.000894	0.0149	CbGeAlD
Tolbutamide—SLCO1A2—liver—hypothyroidism	0.000893	0.0149	CbGeAlD
Tolbutamide—SLC15A2—female gonad—hypothyroidism	0.000884	0.0148	CbGeAlD
Tolbutamide—SLCO1A2—cerebellum—hypothyroidism	0.000873	0.0146	CbGeAlD
Tolbutamide—CYP2C8—blood—hypothyroidism	0.000798	0.0133	CbGeAlD
Tolbutamide—SLC15A2—testis—hypothyroidism	0.000784	0.0131	CbGeAlD
Tolbutamide—SLC15A2—cerebellum—hypothyroidism	0.000724	0.0121	CbGeAlD
Tolbutamide—CYP2C19—liver—hypothyroidism	0.000715	0.0119	CbGeAlD
Tolbutamide—CYP2C9—blood—hypothyroidism	0.000709	0.0118	CbGeAlD
Tolbutamide—KCNJ1—Neuronal System—SLC5A7—hypothyroidism	0.000675	0.0327	CbGpPWpGaD
Tolbutamide—CYP2C8—testis—hypothyroidism	0.00066	0.011	CbGeAlD
Tolbutamide—CYP2C8—liver—hypothyroidism	0.000624	0.0104	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.000609	0.0295	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000575	0.0278	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.000565	0.0274	CbGpPWpGaD
Tolbutamide—CYP2C9—liver—hypothyroidism	0.000554	0.00926	CbGeAlD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.000499	0.0241	CbGpPWpGaD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000498	0.0241	CbGpPWpGaD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.000463	0.0224	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—NEFL—hypothyroidism	0.000435	0.021	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000392	0.019	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000353	0.0171	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—SLC5A7—hypothyroidism	0.000345	0.0167	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—SLC5A7—hypothyroidism	0.000334	0.0162	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000328	0.0159	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000325	0.0157	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000305	0.0148	CbGpPWpGaD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000294	0.0142	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000273	0.0132	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000272	0.0132	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000253	0.0122	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000241	0.0117	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000226	0.011	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—NEFL—hypothyroidism	0.000222	0.0108	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—NEFL—hypothyroidism	0.000215	0.0104	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000199	0.00965	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000199	0.00965	CbGpPWpGaD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000192	0.0093	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000187	0.00907	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000185	0.00897	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000167	0.00808	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000165	0.008	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000157	0.00759	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000156	0.00754	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000155	0.0075	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000154	0.00743	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000138	0.00669	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000131	0.00635	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000128	0.00621	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—IYD—hypothyroidism	0.000125	0.00606	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000123	0.00598	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000122	0.00592	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000122	0.0059	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—IYD—hypothyroidism	0.000121	0.00588	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000115	0.00557	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ATP5O—hypothyroidism	0.000106	0.00515	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000103	0.005	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ATP5O—hypothyroidism	0.000103	0.005	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000101	0.00491	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TPO—hypothyroidism	0.0001	0.00485	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—IYD—hypothyroidism	9.76e-05	0.00472	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TPO—hypothyroidism	9.71e-05	0.0047	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.62e-05	0.00466	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.59e-05	0.00464	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.53e-05	0.00461	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.04e-05	0.00438	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ATP5O—hypothyroidism	8.3e-05	0.00402	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—POMC—hypothyroidism	8.27e-05	0.004	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—IYD—hypothyroidism	8.26e-05	0.004	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.99e-05	0.00387	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.97e-05	0.00386	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TPO—hypothyroidism	7.8e-05	0.00378	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.57e-05	0.00367	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.41e-05	0.00359	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.14e-05	0.00345	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.12e-05	0.00345	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ATP5O—hypothyroidism	7.03e-05	0.0034	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.67e-05	0.00323	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TPO—hypothyroidism	6.61e-05	0.0032	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.51e-05	0.00315	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.48e-05	0.00314	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.27e-05	0.00304	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.19e-05	0.003	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.12e-05	0.00296	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—AVP—hypothyroidism	5.83e-05	0.00282	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.78e-05	0.0028	CbGpPWpGaD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.27e-05	0.00255	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—AVP—hypothyroidism	5.25e-05	0.00254	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.89e-05	0.00237	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.87e-05	0.00236	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TSHB—hypothyroidism	4.64e-05	0.00224	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.6e-05	0.00222	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TSHB—hypothyroidism	4.49e-05	0.00218	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3C2A—hypothyroidism	4.13e-05	0.002	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—IYD—hypothyroidism	4.06e-05	0.00197	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3C2A—hypothyroidism	4.01e-05	0.00194	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—AVP—hypothyroidism	3.85e-05	0.00186	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—IYD—hypothyroidism	3.62e-05	0.00175	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	3.62e-05	0.00175	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TSHB—hypothyroidism	3.61e-05	0.00175	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC5A5—hypothyroidism	3.47e-05	0.00168	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ATP5O—hypothyroidism	3.45e-05	0.00167	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—POMC—hypothyroidism	3.44e-05	0.00167	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC5A5—hypothyroidism	3.36e-05	0.00163	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—IYD—hypothyroidism	3.31e-05	0.0016	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TPO—hypothyroidism	3.25e-05	0.00157	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3C2A—hypothyroidism	3.22e-05	0.00156	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ATP5O—hypothyroidism	3.08e-05	0.00149	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—POMC—hypothyroidism	3.07e-05	0.00149	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TSHB—hypothyroidism	3.06e-05	0.00148	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.01e-05	0.00146	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TPO—hypothyroidism	2.9e-05	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ATP5O—hypothyroidism	2.81e-05	0.00136	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—POMC—hypothyroidism	2.8e-05	0.00136	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3C2A—hypothyroidism	2.73e-05	0.00132	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC5A5—hypothyroidism	2.7e-05	0.00131	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.69e-05	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.69e-05	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TPO—hypothyroidism	2.64e-05	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.45e-05	0.00119	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC5A5—hypothyroidism	2.29e-05	0.00111	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POMC—hypothyroidism	1.82e-05	0.000879	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POMC—hypothyroidism	1.76e-05	0.000852	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TSHB—hypothyroidism	1.5e-05	0.000728	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POMC—hypothyroidism	1.41e-05	0.000685	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TSHB—hypothyroidism	1.34e-05	0.000649	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.34e-05	0.000649	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.32e-05	0.00064	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TSHB—hypothyroidism	1.22e-05	0.000592	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POMC—hypothyroidism	1.2e-05	0.00058	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.2e-05	0.000579	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.18e-05	0.000571	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.13e-05	0.000545	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.09e-05	0.000528	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.08e-05	0.000521	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1e-05	0.000486	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A5—hypothyroidism	9.16e-06	0.000443	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POMC—hypothyroidism	5.89e-06	0.000285	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POMC—hypothyroidism	5.25e-06	0.000254	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POMC—hypothyroidism	4.79e-06	0.000232	CbGpPWpGaD
